Electroencephalographic guided propofol-remifentanil TCI anesthesia with and without dexmedetomidine in a geriatric population: electroencephalographic signatures and clinical evaluation.

Autor: Mehler DM; Department of Anesthesiology and Intensive Care, School of Medicine, Technical University of Munich, Munich, Germany., Kreuzer M; Department of Anesthesiology and Intensive Care, School of Medicine, Technical University of Munich, Munich, Germany., Obert DP; Department of Anesthesiology and Intensive Care, School of Medicine, Technical University of Munich, Munich, Germany.; Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts's General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Cardenas LF; Department of Anesthesiology, Hospital Base San José, Osorno/Universidad Austral, Valdivia, Chile., Barra I; Department of Anesthesiology, Hospital Base San José, Osorno/Universidad Austral, Valdivia, Chile., Zurita F; Department of Anesthesiology, Hospital Base San José, Osorno/Universidad Austral, Valdivia, Chile., Lobo FA; Anesthesiology Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates, Abu Dhabi, UAE., Kratzer S; Department of Anesthesiology and Intensive Care, School of Medicine, Technical University of Munich, Munich, Germany., Schneider G; Department of Anesthesiology and Intensive Care, School of Medicine, Technical University of Munich, Munich, Germany., Sepúlveda PO; Department of Anesthesiology, Hospital Base San José, Osorno/Universidad Austral, Valdivia, Chile. pasevou@gmail.com.
Jazyk: angličtina
Zdroj: Journal of clinical monitoring and computing [J Clin Monit Comput] 2024 Aug; Vol. 38 (4), pp. 803-815. Date of Electronic Publication: 2024 Mar 07.
DOI: 10.1007/s10877-024-01127-4
Abstrakt: Elderly and multimorbid patients are at high risk for developing unfavorable postoperative neurocognitive outcomes; however, well-adjusted and EEG-guided anesthesia may help titrate anesthesia and improve postoperative outcomes. Over the last decade, dexmedetomidine has been increasingly used as an adjunct in the perioperative setting. Its synergistic effect with propofol decreases the dose of propofol needed to induce and maintain general anesthesia. In this pilot study, we evaluate two highly standardized anesthetic regimens for their potential to prevent burst suppression and postoperative neurocognitive dysfunction in a high-risk population. Prospective, randomized clinical trial with non-blinded intervention. Operating room and post anesthesia care unit at Hospital Base San José, Osorno/Universidad Austral, Valdivia, Chile. 23 patients with scheduled non-neurologic, non-cardiac surgeries with age > 69 years and a planned intervention time > 60 min. Patients were randomly assigned to receive either a propofol-remifentanil based anesthesia or an anesthetic regimen with dexmedetomidine-propofol-remifentanil. All patients underwent a slow titrated induction, followed by a target controlled infusion (TCI) of propofol and remifentanil (n = 10) or propofol, remifentanil and continuous dexmedetomidine infusion (n = 13). We compared the perioperative EEG signatures, drug-induced changes, and neurocognitive outcomes between two anesthetic regimens in geriatric patients. We conducted a pre- and postoperative Montreal Cognitive Assessment (MoCa) test and measured the level of alertness postoperatively using a sedation agitation scale to assess neurocognitive status. During slow induction, maintenance, and emergence, burst suppression was not observed in either group; however, EEG signatures differed significantly between the two groups. In general, EEG activity in the propofol group was dominated by faster rhythms than in the dexmedetomidine group. Time to responsiveness was not significantly different between the two groups (p = 0.352). Finally, no significant differences were found in postoperative cognitive outcomes evaluated by the MoCa test nor sedation agitation scale up to one hour after extubation. This pilot study demonstrates that the two proposed anesthetic regimens can be safely used to slowly induce anesthesia and avoid EEG burst suppression patterns. Despite the patients being elderly and at high risk, we did not observe postoperative neurocognitive deficits. The reduced alpha power in the dexmedetomidine-treated group was not associated with adverse neurocognitive outcomes.
(© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
Databáze: MEDLINE
Externí odkaz: